MYH2 Inhibitors

The class of MYH2 inhibitors encompasses a diverse array of chemicals designed to modulate the activity of myosin II, specifically targeting the MYH2 isoform. These inhibitors act through various mechanisms, interfering with key regulatory proteins and pathways involved in the dynamic interplay between actin and myosin II. Blebbistatin and its derivatives directly bind to the myosin ATPase domain, preventing proper actin-myosin interactions and thereby inhibiting MYH2-mediated cellular processes, making them valuable tools for understanding cellular mechanics and interventions. ML-7 and Y-27632 act indirectly by targeting upstream regulators of MYH2, specifically myosin light chain kinase (MLCK) and Rho-associated protein kinase (ROCK), respectively. By modulating the phosphorylation status of the myosin regulatory light chain, these inhibitors influence MYH2 function, shedding light on the intricate signaling pathways governing myosin II activity. Inhibitors like CK-666, CK-869, and CK-548 interfere with actin dynamics by targeting the Arp2/3 complex and formin proteins, crucial players in actin polymerization. These compounds indirectly impact MYH2 function by disrupting the formation of actin filaments, providing insights into the regulatory mechanisms governing MYH2 activity in the context of cellular motility and cytoskeletal dynamics. Furthermore, SMIFH2 and its hydrochloride salt formulation, along with H-1152, add to the diversity of MYH2 inhibitors by targeting formin and ROCK, respectively.